Carvedilol 25mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Carvedilol

Available from:

Milpharm Ltd

ATC code:

C07AG02

INN (International Name):

Carvedilol

Dosage:

25mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 02040000; GTIN: 8901175014040

Patient Information leaflet

PACKAGE LEAFLET: INFORMATION FOR THE USER
Artwork No.
Customer
Description
Market
Language
Size
Min. Font Size
Page No.
Version No.
Date
Software
140519/1
Ennogen
Carvedilol Leaflet
UK
English
240 x 400 mm
9 pt
1 of 1
4
10-12-19
Coreldraw 12
Packaging Development
Quality Assurance (QA)
Quality Control (QC)
Production
e-mail : [e-mail]
Ph : [phone]
Colours Used
Black
Keyline
EN V01
!
have very LOW BLOOD PRESSURE
Talk to your doctor or pharmacist before taking Carvedilol Tablets if
you:
TAKING OTHER MEDICINES
!
suffer from any other HEART PROBLEMS
!
Carvedilol Tablets can affect the results of some blood, urine or
other
tests. If you have a blood or urine test done, tell the doctor or
medical
staff that you are taking Carvedilol Tablets
!
suffer from RAYNAUD'S disease (very poor circulation in the hands and
feet) or another form of peripheral vascular disease
!
wear CONTACT LENSES. Carvedilol can make your eyes become drier
!
suffer from SERIOUS ALLERGIC REACTIONS (abnormal sensitivity to insect
bites or stings, severe eczema, hayfever)
!
suffer from any lung diseases
!
have any problems with your KIDNEYS
!
have problems with the ACID LEVELS in your blood (metabolic acidosis)
!
have a THYROID problem
!
have a condition called PRINZMETAL'S angina
!
have DIABETES and are taking INSULIN or ANTI-DIABETIC tablets. You may
need to monitor your glucose (sugar) levels more closely when you
take Carvedilol Tablets.
!
have severe BLOOD CIRCULATION problems (which may cause your
fingers and toes to tingle or turn pale or blue)
WARNINGS AND PRECAUTIONS
Tell your doctor or pharmacist if you are taking or, have recently
taken or
might take any other medicines. This includes medicines that you buy
without a prescription and herbal medicines. This is because
Carvedilol
Tablets can affect the way some medicines work. Also some medicines
can
affect the way carvedilol works.
!
have PSORIASIS (a skin condition)
!
have an ALLERGY and are having treatment to desensitise you
TAKE SPECIAL CARE WITH CARVEDILOL TABLETS:

Summary of Product characteristics

OBJECT 1
CARVEDILOL 25 MG FILM-COATED TABLETS
Summary of Product Characteristics Updated 10-Nov-2017 | Aurobindo
Pharma - Milpharm Ltd.
1. Name of the medicinal product
Carvedilol 25 mg film-coated tablets
2. Qualitative and quantitative composition
Each tablet contains 25 mg of carvedilol.
Excipient(s) with known effect: Each tablet contains 229 mg of lactose
monohydrate and 5 mg of sucrose.
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Film-coated tablet.
Film-coated tablets white to off-white, oval, engraved with "F59" on
one side and scored on the other
side. The tablet can be divided into equal doses.
4. Clinical particulars
4.1 Therapeutic indications
Essential hypertension
Chronic stable angina pectoris
Adjunctive treatment of moderate to severe stable chronic heart
failure
4.2 Posology and method of administration
Oral use.
ESSENTIAL HYPERTENSION
Carvedilol may be used for the treatment of hypertension alone or in
combination with other
antihypertensives, especially thiazide diuretics. Once daily dosing is
recommended, however the
recommended maximum single dose is 25 mg and the recommended maximum
daily dose is 50 mg.
_Adults: _
The recommended initial dose is 12.5 mg once a day for the first two
days. Thereafter, the treatment is
continued at the dose 25 mg/day. If necessary, the dose may be further
increased gradually at intervals of
two weeks or more rarely.
_Elderly: _
The recommended initial dose in hypertension is 12.5 mg once a day
which may also be sufficient for
continued treatment.
However, if the therapeutic response is inadequate at this dose, the
dose may be further increased
gradually at intervals of two weeks or more rarely.
CHRONIC STABLE ANGINA PECTORIS:
A twice-daily regimen is recommended.
_Adults _
The recommended initial dosage is 12.5 mg twice a day for the first
two days. Thereafter, the treatment is
continued at the dose 25 mg twice a day. If necessary, the dose may be
further increased gradually at
intervals of two weeks or more rarely to the recommended